• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Mangalam Share Price

    Mangalam Drugs And Organics Share PriceMangalam Drugs and Organics

    Small Cap 3.4k Result
    ₹99.5
    2.9 (3%)
    As on 07 December, 2023 | 03:01 BSE: 532637 NSE: MANGALAMISIN: INE584F01014

    Mangalam Drugs And Organics Performance

    Day Range

    • Low 96.00
    • High 102.00
    ₹ 99.5

    52 Week Range

    • Low 93.80
    • High 145.45
    ₹ 99.5
    • Open Price96.60
    • Previous Close96.60
    • Volume181093

    Start SIP in Mangalam Drugs and Organics

    Start SIP

    Mangalam Drugs And Organics Share Price

    • Over 1 Month -1.68%
    • Over 3 Month -5.55%
    • Over 6 Month -5.06%
    • Over 1 Year -27.85%

    Mangalam Drugs And Organics Key Statistics

    P/E Ratio -9.2
    PEG Ratio 0
    Market Cap Cr 158
    Price to Book Ratio 1
    EPS 0.8
    Dividend 0
    Relative Strength Index 52.54
    Money Flow Index 45.53
    MACD Signal -1.15
    Average True Range 3.06

    Mangalam Drugs And Organics Investment Rating

    • Master Rating:

    • Mangalam Drugs & Orgs. has an operating revenue of Rs. 323.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 65 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Mangalam Drugs and Organics Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 82879063108109120
    Operating Expenses Qtr Cr 7991915710099111
    Operating Profit Qtr Cr 2-30681010
    Depreciation Qtr Cr 4333333
    Interest Qtr Cr 3333343
    Tax Qtr Cr -1-1-1011-2
    Net Profit Qtr Cr -4-10-40237
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 373451
    Operating Expenses Annual Cr 347402
    Operating Profit Annual in Cr 2649
    Depreciation Cr 1110
    Interest Annual Cr 1311
    Tax Annual Cr 18
    Net Profit Annual Cr 120
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 26
    Cash from Investing Activity Annual Cr -27
    Cash from Financing Annual Activity Cr 3
    Net Cash Flow Annual Cr 1
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 152151
    Fixed Assets Annual Cr 132141
    Total Non Current Assets Annual Cr 153146
    Total Current Assets Annual Cr 207182
    Total Assets Annual Cr 360328
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 9695
    ROE Annual % 113
    ROCE Annual % 820
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 711
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 533
    Operating Expenses Annual Cr 512
    Operating Profit Annual in Cr 11
    Depreciation Cr 1
    Interest Annual Cr 2
    Tax Annual Cr 6
    Net Profit Annual Cr 12
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2
    Cash from Investing Activity Annual Cr -40
    Cash from Financing Annual Activity Cr 42
    Net Cash Flow Annual Cr 4
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 45
    Fixed Assets Annual Cr 50
    Total Non Current Assets Annual Cr 57
    Total Current Assets Annual Cr 65
    Total Assets Annual Cr 123
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 25
    ROE Annual % 27
    ROCE Annual % 40
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4
    Invest in Mangalam Drugs And Organics

    Mangalam Drugs And Organics Technicals

    EMA & SMA

    Current Price
    ₹99.5
    2.9 (3%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹98.31
    • 50 Day
    • ₹100.21
    • 100 Day
    • ₹102.83
    • 200 Day
    • ₹108.17
    • 20 Day
    • ₹98.14
    • 50 Day
    • ₹100.44
    • 100 Day
    • ₹103.20
    • 200 Day
    • ₹106.40

    Mangalam Drugs And Organics Resistance and Support

    PIVOT
    ₹99.17
    Resistance
    First Resistance 102.33
    Second Resistance 105.17
    Third Resistance 108.33
    RSI 52.54
    MFI 45.53
    MACD Single Line -1.15
    MACD -0.94
    Support
    First Resistance 96.33
    Second Resistance 93.17
    Third Resistance 90.33

    Mangalam Drugs And Organics Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 192,410 10,778,808 56.02
    Week 75,994 4,181,190 55.02
    1 Month 59,954 3,319,059 55.36
    6 Month 72,743 3,324,355 45.7

    Mangalam Drugs And Organics Result Highlights

    Mangalam Drugs and Organics Synopsis

    NSE-Medical-Generic Drugs

    Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 372.25 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2023. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
    Market Cap 158
    Sales 323
    Shares in Float 0.79
    No of funds 4
    Yield 0.68
    Book Value 1.01
    U/D Vol ratio 1.3
    LTDebt / Equity 12
    Alpha -0.16
    Beta 0.41

    Mangalam Drugs and Organics

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 50.32%50.32%50.32%50.32%
    Foreign Portfolio Investors 0.1%0.1%0.1%0.1%
    Financial Institutions/ Banks
    Individual Investors 44.55%44.64%44.22%44.27%
    Others 5.03%4.94%5.36%5.31%

    Mangalam Drugs and Organics Management

    Name Designation
    Mr. Govardhan M Dhoot Chairman & Managing Director
    Mr. Brijmohan M Dhoot Whole Time Director
    Mr. Rakesh K Milwani Non Exe.Non Ind.Director
    Mr. Rukmesh P Dhandhania Independent Director
    Mrs. Nidhi S Mundada Independent Director
    Mr. Praveen Saxena Independent Director

    Mangalam Drugs And Organics Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Mangalam Drugs And Organics Corporate Action

    Date Purpose Remarks
    2023-11-08 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-30 Audited Results
    2023-02-13 Quarterly Results
    2022-11-11 Quarterly Results

    Mangalam Drugs and Organics FAQs

    What is Share Price of Mangalam Drugs and Organics ?

    Mangalam Drugs and Organics share price is ₹99 As on 07 December, 2023 | 02:47

    What is the Market Cap of Mangalam Drugs and Organics ?

    The Market Cap of Mangalam Drugs and Organics is ₹157.5 Cr As on 07 December, 2023 | 02:47

    What is the P/E ratio of Mangalam Drugs and Organics ?

    The P/E ratio of Mangalam Drugs and Organics is -9.2 As on 07 December, 2023 | 02:47

    What is the PB ratio of Mangalam Drugs and Organics ?

    The PB ratio of Mangalam Drugs and Organics is 1 As on 07 December, 2023 | 02:47

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.